Fig. 3From: The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studyNGAL value (ng/dL) 6 h after percutaneous coronary intervention. There was no difference in the primary endpoint of the study. Mean serum NGAL 6 h after PCI was 199 ng/dL in the SGLT2i group and 150 ng/dL in the control group (p = 0.249). *Test-t used to compare two different groupsBack to article page